Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 13-Feb-18 4:59 PM View:  | Oconnell Maureen Director | Sucampo Pharmaceuticals, Inc. (SCMP) | 13-Feb-18 | Disposition | 5,130 | $18.00 | $92,340.00 | (100%) 5.13K to 0 | |
| 13-Feb-18 4:47 PM View: | Pfreundschuh Peter P. CFO | Sucampo Pharmaceuticals, Inc. (SCMP) | 13-Feb-18 | Disposition | 263 | $18.00 | $4,734.00 | (100%) 0.26K to 0 | |
| 13-Feb-18 4:54 PM View: | Edick Paul R Director | Sucampo Pharmaceuticals, Inc. (SCMP) | 13-Feb-18 | Disposition | 14,930 | $18.00 | $268,740.00 | (100%) 14.93K to 0 | |
| 13-Feb-18 4:41 PM View: | Meyenburg Jason Patrick Chief Commercial Officer | Sucampo Pharmaceuticals, Inc. (SCMP) | 13-Feb-18 | Disposition | 30,228 | $18.00 | $544,104.00 | (100%) 30.23K to 0 | |
| 13-Feb-18 4:44 PM View: | Bryan Jones W. Sr. Vice Pres., BD & Licensing | Sucampo Pharmaceuticals, Inc. (SCMP) | 13-Feb-18 | Disposition | 5,139 | $18.00 | $92,502.00 | (100%) 5.14K to 0 | |
| 14-Feb-18 5:47 PM View: | Ueno Ryuji 10% Owner | Sucampo Pharmaceuticals, Inc. (SCMP) | 13-Feb-18 | Disposition (change in control) | 5,406,580 | $18.00 | $97,318,496.00 | (100%) 5.41M to 0 | |
| 13-Feb-18 4:52 PM View: | Johnson John H Director | Sucampo Pharmaceuticals, Inc. (SCMP) | 13-Feb-18 | Disposition | 5,130 | $18.00 | $92,340.00 | (100%) 5.13K to 0 | |
| 13-Feb-18 4:54 PM View: | Donley Matthew Maxwell EVP, Global HR, IT & Strategy | Sucampo Pharmaceuticals, Inc. (SCMP) | 13-Feb-18 | Grant | 36,975 | $18.00 | $665,550.00 | (50%) 73.95K to 36.98K | |
| 14-Feb-18 5:50 PM View: | Kuno Sachiko 10% Owner | Sucampo Pharmaceuticals, Inc. (SCMP) | 13-Feb-18 | Disposition (change in control) | 5,137,340 | $18.00 | $92,472,200.00 | (100%) 5.14M to 0 | |
| 13-Feb-18 4:51 PM View: | Kiener Peter A Chief Science Officer | Sucampo Pharmaceuticals, Inc. (SCMP) | 13-Feb-18 | Disposition | 44,856 | $18.00 | $807,408.00 | (100%) 44.86K to 0 | |
| 13-Feb-18 4:48 PM View: | Lichtlen Peter Chief Medical Officer | Sucampo Pharmaceuticals, Inc. (SCMP) | 13-Feb-18 | Disposition | 24,000 | $18.00 | $432,000.00 | (100%) 24.0K to 0 | |
| 13-Feb-18 4:41 PM View: | Driggs Alex General Counsel & Corp. Sec. | Sucampo Pharmaceuticals, Inc. (SCMP) | 13-Feb-18 | Disposition | 6,084 | $18.00 | $109,512.00 | (100%) 6.08K to 0 | |
| 13-Feb-18 4:54 PM View: | Greenleaf Peter Chief Executive Officer | Sucampo Pharmaceuticals, Inc. (SCMP) | 13-Feb-18 | Disposition | 129,729 | $18.00 | $2,335,120.00 | (100%) 129.73K to 0 | |
| 13-Feb-18 4:57 PM View: | Spiegel Robert J. Director | Sucampo Pharmaceuticals, Inc. (SCMP) | 13-Feb-18 | Disposition | 5,130 | $18.00 | $92,340.00 | (100%) 5.13K to 0 | |
| 13-Feb-18 4:59 PM View: | Walbert Timothy P Director | Sucampo Pharmaceuticals, Inc. (SCMP) | 13-Feb-18 | Disposition | 5,130 | $18.00 | $92,340.00 | (100%) 5.13K to 0 | |
| 14-Feb-18 5:47 PM View: | Ueno Ryuji 10% Owner | Sucampo Pharmaceuticals, Inc. (SCMP) | 29-Jan-18 | Gift | 2,000,000 | -- | -- | (27%) 7.41M to 5.41M | |
| 14-Feb-18 5:50 PM View: | Kuno Sachiko 10% Owner | Sucampo Pharmaceuticals, Inc. (SCMP) | 25-Jan-18 | Gift | 2,000,000 | -- | -- | (28%) 7.14M to 5.14M | |
| 12-Jan-18 4:36 PM View: | Bryan Jones W. Sr. Vice Pres., BD & Licensing | Sucampo Pharmaceuticals, Inc. (SCMP) | 31-Dec-17 | Grant | 439 | $10.24 | $4,495.36 | 9% 4.7K to 5.14K | 74% |
| 04-Jan-18 5:15 PM View: | Donley Matthew Maxwell EVP, Global HR, IT & Strategy | Sucampo Pharmaceuticals, Inc. (SCMP) | 31-Dec-17 | Grant | 330 | $9.10 | $3,003.00 | < 1% 36.65K to 36.98K | |
| 04-Jan-18 5:16 PM View: | Kiener Peter A Chief Science Officer | Sucampo Pharmaceuticals, Inc. (SCMP) | 31-Dec-17 | Grant | 329 | $9.10 | $2,993.90 | < 1% 44.53K to 44.86K | |
| 04-Jan-18 5:15 PM View: | Driggs Alex General Counsel & Corp. Sec. | Sucampo Pharmaceuticals, Inc. (SCMP) | 31-Dec-17 | Grant | 660 | $9.10 | $6,006.00 | 12% 5.42K to 6.08K | |
| 04-Jan-18 5:16 PM View: | Greenleaf Peter Chief Executive Officer | Sucampo Pharmaceuticals, Inc. (SCMP) | 31-Dec-17 | Grant | 171 | $9.10 | $1,556.10 | 4% 4.62K to 4.79K | |
| 12-Jan-18 6:05 PM View: | Pfreundschuh Peter P. CFO | Sucampo Pharmaceuticals, Inc. (SCMP) | 31-Dec-17 | Grant | 263 | $9.10 | $2,393.30 | 100% 0 to 0.26K | |
| 02-Jan-18 5:00 PM View: | Kiener Peter A Chief Science Officer | Sucampo Pharmaceuticals, Inc. (SCMP) | 28-Dec-17 | Payment of Exercise | 27,496 | $17.98 | $494,378.00 | (38%) 72.02K to 44.53K | |
| 02-Jan-18 4:56 PM View: | Driggs Alex General Counsel & Corp. Sec. | Sucampo Pharmaceuticals, Inc. (SCMP) | 28-Dec-17 | Payment of Exercise | 2,025 | $17.98 | $36,409.50 | (27%) 7.45K to 5.42K | |
| 02-Jan-18 4:58 PM View: | Donley Matthew Maxwell EVP, Global HR, IT & Strategy | Sucampo Pharmaceuticals, Inc. (SCMP) | 28-Dec-17 | Payment of Exercise | 19,353 | $17.98 | $347,967.00 | (35%) 56.0K to 36.65K | |
| 14-Feb-18 5:47 PM View: | Ueno Ryuji 10% Owner | Sucampo Pharmaceuticals, Inc. (SCMP) | 19-Dec-17 | Gift | 600,000 | -- | -- | (7%) 8.01M to 7.41M | |
| 11-Dec-17 5:30 PM View: | Kiener Peter A Chief Science Officer | Sucampo Pharmaceuticals, Inc. (SCMP) | 07-Dec-17 | Option Exercise | 50,000 | $8.33 | $416,500.00 | 2472% 2.02K to 52.02K | |
| 11-Dec-17 5:30 PM View: | Kiener Peter A Chief Science Officer | Sucampo Pharmaceuticals, Inc. (SCMP) | 07-Dec-17 | Market Option Sale | 50,000 | $16.50 | $825,000.00 | (96%) 52.02K to 2.02K | |
| 05-Oct-17 4:32 PM View: | Greenleaf Peter CEO | Sucampo Pharmaceuticals, Inc. (SCMP) | 30-Sep-17 | Grant | 659 | $9.10 | $5,996.90 | 17% 3.96K to 4.62K | |
| 05-Oct-17 4:40 PM View: | Kiener Peter A Chief Science Officer | Sucampo Pharmaceuticals, Inc. (SCMP) | 30-Sep-17 | Grant | 330 | $9.10 | $3,003.00 | 19% 1.69K to 2.02K | |
| 05-Oct-17 4:35 PM View: | Driggs Alex General Counsel & Corp. Sec. | Sucampo Pharmaceuticals, Inc. (SCMP) | 30-Sep-17 | Grant | 659 | $9.10 | $5,996.90 | 98% 0.67K to 1.33K | |
| 12-Jan-18 6:05 PM View: | Pfreundschuh Peter P. CFO | Sucampo Pharmaceuticals, Inc. (SCMP) | 30-Sep-17 | Grant | 131 | $9.10 | $1,192.10 | 100% 0 to 0.13K | |
| 05-Oct-17 4:37 PM View: | Donley Matthew Maxwell EVP, Global HR, IT & Strategy | Sucampo Pharmaceuticals, Inc. (SCMP) | 30-Sep-17 | Grant | 330 | $9.10 | $3,003.00 | 12% 2.67K to 3.0K | |
| 13-Sep-17 5:50 PM View: | Ueno Ryuji 10% Owner | Sucampo Pharmaceuticals, Inc. (SCMP) | 11-Sep-17 | Market Sale Duplicate | 1,000,000 | $12.00 | $12,000,000.00 | (11%) 9.01M to 8.01M | (49%) |
| 13-Sep-17 5:50 PM View: | Kuno Sachiko 10% Owner | Sucampo Pharmaceuticals, Inc. (SCMP) | 11-Sep-17 | Market Sale | 1,000,000 | $12.00 | $12,000,000.00 | (12%) 8.14M to 7.14M | (49%) |
| 08-Sep-17 4:40 PM View: | Meyenburg Jason Patrick Chief Commercial Officer | Sucampo Pharmaceuticals, Inc. (SCMP) | 06-Sep-17 | Market Purchase | 4,000 | $12.12 | $48,500.00 | 15% 26.23K to 30.23K | 47% |
| 07-Aug-17 4:35 PM View: | Bryan Jones W. Sr. Vice Pres., BD & Licensing | Sucampo Pharmaceuticals, Inc. (SCMP) | 04-Aug-17 | Market Purchase | 4,700 | $10.60 | $49,820.00 | 100% 0 to 4.7K | 68% |
| 07-Jul-17 4:40 PM View: | Driggs Alex Acting General Counsel | Sucampo Pharmaceuticals, Inc. (SCMP) | 30-Jun-17 | Grant | 672 | $8.93 | $6,000.96 | 100% 0 to 0.67K | |
| 07-Jul-17 4:35 PM View: | Donley Matthew Maxwell EVP, Global HR, IT & Strategy | Sucampo Pharmaceuticals, Inc. (SCMP) | 30-Jun-17 | Grant | 336 | $8.93 | $3,000.48 | 14% 2.33K to 2.67K | |
| 07-Jul-17 4:45 PM View: | Greenleaf Peter CEO | Sucampo Pharmaceuticals, Inc. (SCMP) | 30-Jun-17 | Grant | 673 | $8.93 | $6,009.89 | 20% 3.29K to 3.96K | |
| 07-Jul-17 4:46 PM View: | Kiener Peter A Chief Science Officer | Sucampo Pharmaceuticals, Inc. (SCMP) | 30-Jun-17 | Grant | 336 | $8.93 | $3,000.48 | 25% 1.36K to 1.69K | |
| 07-Jul-17 4:30 PM View: | Alder Matthias EVP, Gen. Council & Sec. | Sucampo Pharmaceuticals, Inc. (SCMP) | 30-Jun-17 | Grant | 673 | $8.93 | $6,009.89 | 16% 4.09K to 4.76K | |
| 05-Jun-17 9:59 PM View: | Edick Paul R Director | Sucampo Pharmaceuticals, Inc. (SCMP) | 01-Jun-17 | Grant | 5,130 | -- | -- | 52% 9.8K to 14.93K | |
| 05-Jun-17 9:55 PM View: | Johnson John H Director | Sucampo Pharmaceuticals, Inc. (SCMP) | 01-Jun-17 | Grant | 5,130 | -- | -- | 52% 9.8K to 14.93K | |
| 05-Jun-17 9:56 PM View: | Spiegel Robert J. Director | Sucampo Pharmaceuticals, Inc. (SCMP) | 01-Jun-17 | Grant | 5,130 | -- | -- | 52% 9.8K to 14.93K | |
| 05-Jun-17 9:57 PM View: | Walbert Timothy P Director | Sucampo Pharmaceuticals, Inc. (SCMP) | 01-Jun-17 | Grant | 5,130 | -- | -- | 52% 9.8K to 14.93K | |
| 05-Jun-17 9:56 PM View: | Oconnell Maureen Director | Sucampo Pharmaceuticals, Inc. (SCMP) | 01-Jun-17 | Grant | 5,130 | -- | -- | 52% 9.8K to 14.93K | |
| 10-May-17 4:02 PM View: | Donley Matthew Maxwell EVP, Global HR, IT & Strategy | Sucampo Pharmaceuticals, Inc. (SCMP) | 31-Mar-17 | Grant | 321 | $9.35 | $3,001.35 | 16% 2.01K to 2.33K | |
| 10-May-17 4:02 PM View: | Greenleaf Peter CEO | Sucampo Pharmaceuticals, Inc. (SCMP) | 31-Mar-17 | Grant | 641 | $9.35 | $5,993.35 | 24% 2.65K to 3.29K |
